Tensi+ European Registry

Sponsor
Stimuli Technology
Study ID
NCT07205445
Status
Recruiting
Apply to this trial

Conditions

  • Overactive Bladder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tensi+ — DEVICE
    Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management.

Study Details

Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. Preliminary studies have shown a favorable safety and efficacy profile. The goal of the present registry is to collect data among an important number of patients to assess the efficacy, safety and potential predictive factors of success in a current clinical setting over a total period of 1 year.

Key Dates

First listed
Oct 3, 2025
Start date
Feb 27, 2025
Status verified
Sep 2025
Primary completion
Oct 1, 2027
Completion
Oct 1, 2027

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Subjective improvement [ Time Frame: 3 and 12 months ]

Central Contacts

Related Studies